# EDGAR Filing Document

**Accession Number:** 0001874097
**File Stem:** 0001213900-26-008954
**Filing Date:** 2026-1
**Character Count:** 66346
**Document Hash:** 0ab62e7c131d2dd68512bf2307b831fb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-008954.hdr.sgml**: 20260128

**ACCESSION NUMBER**: 0001213900-26-008954

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20260128

**DATE AS OF CHANGE**: 20260128

**EFFECTIVENESS DATE**: 20260128

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cyngn Inc.
- **CENTRAL INDEX KEY:** 0001874097
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 462007094
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293025
- **FILM NUMBER:** 26573727

**BUSINESS ADDRESS:**
- **STREET 1:** 1344 TERRA BELLA AVENUE
- **CITY:** MOUNTAIN VIEW
- **STATE:** CA
- **ZIP:** 94043
- **BUSINESS PHONE:** 650-924-5905

**MAIL ADDRESS:**
- **STREET 1:** 1344 TERRA BELLA AVENUE
- **CITY:** MOUNTAIN VIEW
- **STATE:** CA
- **ZIP:** 94043

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Cyngn, Inc.
- **DATE OF NAME CHANGE:** 20210721

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933**

**CYNGN INC.**

(*Exact name of Registrant as specified in its charter*)

---

| | |
|:---|:---|
| **Delaware** | **46-2007094** |
| *(State or other jurisdiction of* | *(I.R.S. Employer* |
| *incorporation or organization)* | *Identification Number)* |

---

**1344 Terra Bella**

**Mountain View, CA 94043<br> (650) 924-5905**

*(Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices)*

 

**Cyngn Inc. 2021 Incentive Plan** 

*(Full title of the plan)*

 

**Lior Tal<br> Chief Executive Officer<br> Cyngn Inc.**

**1344 Terra Bella**

**Mountain View, CA 94043** 

**(650) 924-5905**

*(Name, address, including zip code, and telephone number, including area code, of agent for service)*

 **

***Please send copies of all communications to:***

 

**Gregory Sichenzia, Esq.**

**Marcelle S. Balcombe, Esq.**

**Sichenzia Ross Ference Carmel LLP**

**1185 Avenue of the Americas, 31<sup>st</sup> Floor**

**New York, NY 10036**

**(212) 930-9700**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**EXPLANATORY NOTE**

This Registration Statement on Form S-8 (this "**Registration Statement**") is being filed by Cyngn Inc., a Delaware corporation (the "**Company**") to register an additional 5,274,000 shares of common stock, $0.00001 par value per share (the "**Common Stock**"), issuable under Cyngn Inc.'s 2021 Equity Incentive Plan, as amended (the "**Plan**"), consisting of:

● 4,000,000 shares of Common Stock authorized for issuance pursuant to an amendment to the Plan approved on December 3, 2025 by the Company's stockholders; and

● 1,274,000 shares of Common Stock that became available for issuance under the Plan on January 1, 2026 as a result of the Plan's evergreen provision. The 1,274,000 shares of Common Stock were added to the total number of shares of Common Stock reserved for issuance under the Plan. Pursuant to the evergreen provision, on January 1 of each year the number of shares authorized for issuance under the Plan is automatically increased by a number equal to the least of: (a) 15% of the outstanding Common Stock on a fully diluted basis as of the end of the Company's immediately preceding fiscal year; or (b) a lesser amount determined by the Company's board of directors.

The Registration Statement also includes in Part I of the Registration Statement a reoffer prospectus (the "**Reoffer Prospectus**") prepared in accordance with General Instruction C of Form S-8 and in accordance with the requirements of Part I of Form S-3. This Reoffer Prospectus may be used for the reoffer and resale of shares of Common Stock on a continuous or delayed basis that may be deemed to be "restricted securities" and/or "control securities" within the meaning of the Securities Act of 1933, as amended (the "**Securities Act**"), and the rules and regulations promulgated thereunder, that are issuable to certain of our executive officers, employees, consultants and directors identified in the Reoffer Prospectus. The number of shares of Common Stock included in the Reoffer Prospectus represents shares of Common Stock issuable to the selling stockholders pursuant to equity awards, including stock options and restricted stock grants, granted to the selling stockholders and does not necessarily represent a present intention to sell any or all such shares of Common Stock.

Pursuant to General Instruction E of Form S-8, the contents of the prior registration statements on Form S-8, File No. 333-286030, File No. 333-276792 and File No. 333-262130, previously filed with respect to the Plan, are incorporated into this Registration Statement by reference to the extent not modified or superseded hereby or by any subsequently filed document, which is incorporated by reference herein or therein.

**PART I** 

**INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS** 

**Item 1. Plan Information.**

The Company will provide each recipient of a grant under the Plan (the "**Recipients**") with documents that contain information related to the Plan, and other information including, but not limited to, the disclosure required by Item 1 of Form S-8, which information is not required to be and is not being filed as a part of this Registration Statement on Form S-8 (the "**Registration Statement**") or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act. The foregoing information and the documents incorporated by reference in response to Item 3 of Part II of this Registration Statement, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act. A Section 10(a) prospectus will be given to each Recipient who receives shares of Common Stock covered by this Registration Statement, in accordance with Rule 428(b)(1) under the Securities Act.

**Item 2. Registrant Information and Employee Plan Annual Information.** 

The documents containing the information specified in Part I of this Registration Statement will be sent or given to participants in the Plan, as specified by Rule 428(b)(1) promulgated under the Securities Act. Such documents need not be filed with the Securities and Exchange Commission (the "**Commission**" or the "**SEC**") either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 promulgated under the Securities Act. These documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a prospectus that meets the requirement of Section 10(a) of the Securities Act.

Lior Tal

Chief Executive Officer

Cyngn Inc.

1344 Terra Bella

Mountain View, CA 94043

**REOFFER PROSPECTUS**

**CYNGN INC.** 

**Up to 706 Shares of Common Stock**

**Issuable under certain grants under**

**the 2021 Equity Incentive Plan**

This reoffer prospectus relates to the public resale, from time to time, of an aggregate of 706 shares (the "**Shares**") of our common stock, $0.00001 par value per share (the "**Common Stock**") by certain security holders identified herein in the section entitled "Selling Securityholders". Such shares may be acquired in connection with common stock underlying options issued under the 2021 Equity Incentive Plan (the "Plan"). You should read this prospectus carefully before you invest in our Common Stock.

Such resales shall take place on Nasdaq, or such other stock market or exchange on which our Common Stock may be listed or quoted, in negotiated transactions or otherwise, at market prices prevailing at the time of the sale or at prices otherwise negotiated (see "Plan of Distribution" starting on page 7 of this prospectus). We will receive no part of the proceeds from sales made under this reoffer prospectus. The Selling Securityholders will bear all sales commissions and similar expenses. Any other expenses incurred by us in connection with the registration and offering and not borne by the Selling Securityholders will be borne by us.

This reoffer prospectus has been prepared for the purposes of registering our shares of Common Stock under the Securities Act to allow for future sales by Selling Securityholders on a continuous or delayed basis to the public without restriction, provided that the amount of shares of Common Stock to be offered or resold under this Reoffer Prospectus by each Selling Securityholder or other person with whom he or she is acting in concert for the purpose of selling shares of Common Stock, may not exceed, during any three-month period, the amount specified in Rule 144(e) under the Securities Act. We have not entered into any underwriting arrangements in connection with the sale of the shares covered by this reoffer prospectus. The Selling Securityholders identified in this reoffer prospectus, or their pledgees, donees, transferees or other successors-in-interest, may offer the shares covered by this reoffer prospectus from time to time through public or private transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices.

Investing in our Common Stock involves risks. See "Risk Factors" beginning on page 4 of this reoffer prospectus. These are speculative securities.

Our Common Stock is quoted on the Nasdaq Capital Market under the symbol "CYN" and the last reported sale price of our Common Stock on January 27, 2026 was $2.02 per share.

**NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.**

The date of this prospectus is January 28, 2026

**CYNGN INC.**

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
|  | **Page** |
| [Cautionary Statement Regarding Forward-Looking Statements](#k_001) | ii |
| [Prospectus Summary](#k_002) | 1 |
| [Risk Factors](#k_003) | 4 |
| [Use of Proceeds](#k_004) | 5 |
| [Selling Securityholders](#k_005) | 5 |
| [Plan of Distribution](#k_006) | 7 |
| [Legal Matters](#k_007) | 8 |
| [Experts](#k_008) | 8 |
| [Incorporation of Certain Documents by Reference](#k_009) | 9 |
| [Where You can Find Additional Information](#k_010) | 9 |

---

 

i

**CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS**

This prospectus and the documents and information incorporated by reference in this prospectus include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These statements are based on our management's beliefs and assumptions and on information currently available to our management. Such forward-looking statements include those that express plans, anticipation, intent, contingency, goals, targets or future development and/or otherwise are not statements of historical fact.

All statements in this prospectus and the documents and information incorporated by reference in this prospectus that are not historical facts are forward-looking statements. We may, in some cases, use terms such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "should," "will," "would" or similar expressions or the negative of such items that convey uncertainty of future events or outcomes to identify forward-looking statements.

Forward-looking statements are made based on management's beliefs, estimates and opinions on the date the statements are made and we undertake no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as may be required by applicable law. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.

We caution you therefore that you should not rely on any of these forward-looking statements as statements of historical fact or as guarantees or assurances of future performance.

Information regarding market and industry statistics contained in this prospectus, including the documents that we incorporate by reference, is included based on information available to us that we believe is accurate. It is generally based on academic and other publications that are not produced for purposes of securities offerings or economic analysis. Forecasts and other forward-looking information obtained from these sources are subject to the same qualifications and the additional uncertainties accompanying any estimates of future market size, revenue and market acceptance of products and services. Except as required by U.S. federal securities laws, we have no obligation to update forward-looking information to reflect actual results or changes in assumptions or other factors that could affect those statements.

ii

**PROSPECTUS SUMMARY**

*The Commission allows us to* ''*incorporate by reference*'' *certain information that we file with the Commission, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus, and information that we file later with the Commission will update automatically, supplement and/or supersede the information disclosed in this prospectus. Any statement contained in a document incorporated or deemed to be incorporated by reference in this prospectus shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or in any other document that also is or is deemed to be incorporated by reference in this prospectus modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus. You should read the following summary together with the more detailed information regarding our company, our Common Stock and our financial statements and notes to those statements appearing elsewhere in this prospectus or incorporated herein by reference.*

 

*Except where the context otherwise requires, the terms,* "*we,*" "*us,*" "*our*" *or* "*the Company,*" *refer to the business of Cyngn Inc., a Delaware corporation.*

 

**Our Company**

We are an autonomous vehicle ("AV") technology company that is focused on addressing industrial uses for autonomous vehicles. We believe that technological innovation is needed to enable adoption of autonomous industrial vehicles that will address the substantial industry challenges that exist today. These challenges include labor shortages, lagging technological advancements from incumbent vehicle manufacturers, and high upfront investment commitment.

Industrial sites are typically rigid environments with consistent standards as opposed to city streets that have more variable environmental and situational conditions and diverse regulations. These differences in operational design domains will be major factors that make proliferation of industrial AVs in private settings achievable with less time and resources than AVs on public roadways. Namely, safety and infrastructure challenges are cited as roadblocks that have delayed AVs from operating on public roadways at scale. Our focus on industrial AVs simplifies these challenges because industrial facilities (especially those belonging to a single end customer that operates similarly at different sites) share much more in common than different cities do. Furthermore, our end customers own their infrastructure and can make changes more easily than governments can on public roadways.

With these challenges in mind, we are developing an Enterprise Autonomy Suite ("EAS") that leverages advanced in-vehicle autonomous driving technology and incorporates leading supporting technologies like data analytics, asset tracking, fleet management, cloud, and connectivity. EAS provides a differentiated solution that we believe will drive pervasive proliferation of industrial autonomy and create value for customers at every stage of their journey towards full automation and the adoption of Industry 4.0.

EAS is a suite of technologies and tools that we divide into three complementary categories:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. DriveMod, our modular industrial vehicle autonomous driving software;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Cyngn Insight, our customer-facing tool suite for monitoring and managing AV fleets (including remotely operated vehicles) and generating/aggregating/analyzing data (including the IoT gateway device); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Cyngn Evolve, our internal tool suite and infrastructure that facilitates artificial intelligence ("AI") and machine learning ("ML") training to continuously enhance our algorithms and models and provides a simulation framework (both record/rerun and synthetic scenario creation) to ensure that data collected in the field can be applied to validating new releases.

Legacy automation providers manufacture specialized industrial vehicles with integrated robotics software for rigid tasks, limiting automation to narrow uses. Unlike these specialized vehicles, EAS can be compatible with the existing vehicle assets in addition to new vehicles that have been purposely built for autonomy by vehicle manufacturers. EAS is operationally expansive, vehicle agnostic, and compatible with indoor and outdoor environments. By offering flexible autonomous services, we aim to remove barriers to industry adoption.

We understand that scaling of autonomy solutions will require an ecosystem made up of different technologies and services that are enablers for AVs. Our approach is to forge strategic collaborations with complementary technology providers that accelerate AV development and deployment, provide access to new markets, and create new capabilities. Our focus on designing DriveMod to be modular will combine with our experience deploying AV technology on diverse industrial vehicle form factors, which will be difficult for competitors to replicate.

We expect our technology to generate revenue through two main methods: deployment and EAS subscriptions. Deploying our EAS requires us and our integration partners to work with a new client to map the facility, gather data, and install our AV technology within their fleet and site. We anticipate that new deployments will yield project-based revenues based on the scope of the deployment. After deployment, we expect to generate revenues by offering EAS through a Software as a Service ("SaaS") model, which can be considered the AV software component of Robotics as a Service ("RaaS").

RaaS is a subscription model that allows customers to use robots/vehicles without purchasing the hardware assets upfront. We will seek to achieve sustained revenue growth largely from ongoing SaaS-style EAS subscriptions that enable companies to tap into our ever-expanding suite of AV and AI capabilities as organizations transition into full industrial autonomy.

Although both the components and the combined solutions of EAS are still under development, we have EAS licenses with paying customers and have piloted EAS for paid customer trial and pilot deployments. We expect EAS to continually be developed and enhanced according to evolving customer needs, which will take place concurrently while other completed features of EAS are commercialized. We expect annual R&D expenditures in the foreseeable future to exceed that of 2024. We also had limited paid deployments in 2024 that offset some of the ongoing R&D costs of continually developing EAS.

Our go-to-market strategy is to acquire new customers that use industrial vehicles in their mission-critical and daily operations by (a) leveraging the relationships and existing customers of our network of strategic partners, (b) bringing AV capabilities to industrial vehicles as a software service provider, and (c) executing a robust in-house sales and marketing effort to nurture a pipeline of industrial organizations. Our focus is on acquiring new customers who are either looking (a) to embed our technology into their vehicle product roadmaps or (b) to apply autonomy to existing fleets with our vehicle retrofits. In turn, our customers are any organizations that could utilize our EAS solution, including original equipment manufacturers ("OEMs") that supply industrial vehicles, end customers that operate their own industrial vehicles, or service providers that operate industrial vehicles for end customers.

As OEMs and leading industrial vehicle users seek to increase productivity, reinforce safer working environments, and scale their operations, we believe we are uniquely positioned to deliver a dynamic autonomy solution via our EAS to a wide variety of industrial uses. Our long-term vision is for EAS to become a universal autonomous driving solution with minimal marginal cost for companies to adopt new vehicles and expand their autonomous fleets across new deployments. We have already deployed DriveMod software on more than 10 different vehicle form factors that range from stockchasers and forklifts to 14-seat shuttles and 5-meter-long cargo vehicles demonstrating the extensibility of our AV building blocks.

Our strategy upon establishing a customer relationship with an OEM is to seek to embed our technology into their vehicle roadmap and expand our services to their many clients. Once we solidify an initial AV deployment with a customer, we intend to seek to expand within the site to additional vehicle platforms and/or expand the use of similar vehicles to other sites operated by the customer. This "land and expand" strategy can repeat iteratively across new vehicles and sites and is at the heart of why we believe industrial AVs that operate in geo-fenced, constrained environments are poised to create value.

**Corporate Information**

The Company was originally incorporated in the State of Delaware on February 1, 2013, under the name Cyanogen, Inc. or Cyanogen. The Company started as a venture funded company with offices in Seattle and Palo Alto, aimed at commercializing CyanogenMod, direct to consumer and through collaborations with mobile phone manufacturers. CyanogenMod was an open-source operating system for mobile devices, based on the Android mobile platform. Cyanogen released multiple versions of its mobile operating system and collaborated with an ecosystem of companies including mobile phone OEMs, content providers and leading technology partners from 2013 to 2015.

In 2016 the Company's management and board of directors, determined to pivot its product focus and commercial direction from the mobile device and telecom space to industrial and commercial autonomous driving with the hiring of Lior Tal in June 2016 to serve as the company's chief operating officer. Mr. Tal, a seasoned executive of startup firms prior to joining the company, co-founded Snaptu which later was acquired by Facebook (currently known as Meta Platforms, Inc.), as well as held various leadership roles at Actimize, DiskSites and Odigo; all of these companies which were also later acquired. Mr. Tal was promoted to chief executive officer in October 2016 and continues to serve in this role along with chairman of the board. In May 2017, the Company changed its name to CYNGN Inc.

Our principal business address is 1344 Terra Bella Ave., Mountain View, CA 94043. We maintain our corporate website at *https://cyngn.com*. The reference to our website is an inactive textual reference only. The information that can be accessed through our website is not part of this reoffer prospectus.

**THE OFFERING**

---

| | |
|:---|:---|
| **Outstanding Common Stock:** | 7,974,380 shares of our Common Stock are outstanding as of January 14, 2026. |
| **Common Stock Offered:** | Up to 706 shares of Common Stock for sale by the selling securityholders (which include our executive officers and directors) for their own account pursuant to the Plan. |
| **Selling Securityholders:** | The selling securityholders are set forth in the section entitled "Selling Securityholders" of this reoffer prospectus on page 5. The amount of securities to be offered or resold by means of the reoffer prospectus by the designated selling securityholders may not exceed, during any three month period, the amount specified in Rule 144(e). |
| **Use of proceeds:** | We will not receive any proceeds from the sale of our Common Stock by the selling securityholders. We would, however, receive proceeds upon the exercise of the stock options by those who receive options under the Plan and exercise such options for cash. Any cash proceeds will be used by us for general corporate purposes. |
| **Risk Factors:** | The securities offered hereby involve a high degree of risk. See "Risk Factors." |
| **Nasdaq trading symbol:** | CYN |

---

**RISK FACTORS**

*An investment in shares of our Common Stock is highly speculative and involves a high degree of risk. We face a variety of risks that may affect our operations or financial results and many of those risks are driven by factors that we cannot control or predict. Before investing in our Common Stock, you should carefully consider the risks below and set forth under the caption "Risk Factors" and elsewhere in our most recent Annual Report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, that we have file with the Securities and Exchange Commission (the "SEC"), which are incorporated by reference herein, and subsequent reports filed with the SEC, together with the financial and other information contained or incorporated by reference in this prospectus. If any of these risks actually occurs, our business, prospects, financial condition and results of operations could be materially adversely affected. In that case, the trading price of our Common Stock would likely decline and you may lose all or a part of your investment. Only those investors who can bear the risk of loss of their entire investment should invest in our Common Stock.*

**USE OF PROCEEDS**

The shares which may be sold under this reoffer prospectus will be sold for the respective accounts of each of the Selling Securityholders listed herein (which includes our executive officers and directors). Accordingly, we will not realize any proceeds from the sale of the shares of our Common Stock. We will receive proceeds from the exercise of the options; however, no assurance can be given as to when or if any or all of the options will be exercised. If any options are exercised, the proceeds derived therefrom will be used for working capital and general corporate purposes. All expenses of the registration of the shares will be paid by us. See "Selling Securityholders" and "Plan of Distribution."

**SELLING SECURITYHOLDERS**

We are registering for resale the shares covered by this prospectus to permit the Selling Securityholders identified below and their pledgees, donees, transferees and other successors-in-interest that receive their securities from a Selling Securityholder as a gift, partnership distribution or other non-sale related transfer after the date of this prospectus to resell the shares when and as they deem appropriate. The Selling Securityholders acquired, or may acquire, these shares from us pursuant to the Plan. The shares may not be sold or otherwise transferred by the Selling Securityholders unless and until the applicable awards vest and are exercised, as applicable, in accordance with the terms and conditions of the Plan.

The following table sets forth:

● the name of each Selling Securityholder;

● the number and percentage of shares of our Common Stock that each Selling Securityholder beneficially owned as of January 14, 2025 prior to the offering for resale of the shares under this prospectus;

● the number of shares of our Common Stock that may be offered for resale for the account of each Selling Securityholder under this prospectus; and

● the number and percentage of shares of our Common Stock to be beneficially owned by each Selling Securityholder after the offering of the resale shares (assuming all of the offered resale shares are sold by such Selling Securityholder).

Information with respect to beneficial ownership is based upon information obtained from the Selling Securityholders. Because the Selling Securityholders may offer all or part of the shares of Common Stock, which they own pursuant to the offering contemplated by this reoffer prospectus, and because its offering is not being underwritten on a firm commitment basis, no estimate can be given as to the amount of shares that will be held upon termination of this offering.

The number of shares in the column ''Number of Shares Being Offered'' represents all of the shares of our Common Stock that each Selling Securityholder may offer under this prospectus. We do not know how long the Selling Securityholders will hold the shares before selling them or how many shares they will sell. The shares of our Common Stock offered by this prospectus may be offered from time to time by the Selling Securityholders listed below. We cannot assure you that any of the Selling Securityholders will offer for sale or sell any or all of the shares of Common Stock offered by them by this prospectus.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Number of Shares<br> Beneficially<br> Owned<br> Prior to the <br> Offering (1)** | **Number of Shares<br> Beneficially<br> Owned<br> Prior to the <br> Offering (1)** | | **Number of Shares<br> Beneficially<br> Owned After<br> Completion of the<br> Offering (3)** | **Number of Shares<br> Beneficially<br> Owned After<br> Completion of the<br> Offering (3)** |
| <br>**Securityholders** | **Number** | **Percent <br> (%)** | **Number of<br> Shares Being**<br>**Offered Hereby (2)** | **Number** | **Percent<br> (%)** |
| Lior Tal (4) | 608 | \* | 682 | 74 | \* |
| Natalie Russell (5) | 2 | \* | 3 | 1 | \* |
| Karen Macleod (6) | 11 | \* | 11 | 0 | \* |
| James McDonnell (7) | 10 | \* | 10 | 0 | \* |

---

\* less than 1%

1. The number and percentage of shares beneficially owned is determined in accordance with Rule 13d-3 of
the Securities Exchange Act of 1934, as amended, and the information is not necessarily indicative of beneficial ownership for any other
purpose. Under such rule, beneficial ownership includes any shares as to which the Selling Securityholder has sole or shared voting power
or investment power and also any shares which the Selling Securityholder has the right to acquire within 60 days. Applicable percentage
ownership is based on 7,974,380 shares of Common Stock outstanding as of January 14, 2026.

2. The number of shares of Common Stock offered for resale in this offering reflect all shares of Common
Stock acquired or issuable to a person pursuant to applicable awards and grants, including options and restricted stock units, previously
made irrespective of whether such grants are vested or convertible as of January 14, 2026 or will become vested or convertible within
60 days.

3. Assumes that all shares of Common Stock to be offered, as set forth above, are sold pursuant to this offering
and that no other shares of Common Stock are acquired or disposed of by the Selling Securityholders prior to the termination of this offering.
Because the Selling Securityholders may sell all, some or none of their shares of Common Stock or may acquire or dispose of other shares
of Common Stock, no reliable estimate can be made of the aggregate number of shares of Common Stock that will be sold pursuant to this
offering or the number or percentage of shares of Common Stock that each Selling Securityholder will own upon completion of this offering.

4. Mr. Tal is our Chief Executive Officer and Chairman of the Board. Consists of: (a) 34 shares of Common
Stock; and (b) 648 shares of Common Stock underlying stock options issued under the Plan, 574 of which are or will become exercisable
within 60 days.

5. Ms. Russell is our Chief Financial Officer. Consists of 3 shares of Common Stock underlying stock options
issued under the Plan, 2 of which are or will become exercisable within 60 days.

6. Ms. Macleod is a Director of the Company. Consists of 11 shares of Common Stock underlying restricted
stock units issued under the Plan, of which all are or will become vested within 60 days.

7. Mr. McDonnell is a Director of the Company. Consists of 10 shares of Common Stock underlying restricted
stock units issued under the Plan, of which all are or will become vested within 60 days.

**PLAN OF DISTRIBUTION**

We are registering the Shares covered by this prospectus to permit the Selling Stockholders to conduct public secondary trading of these Shares from time to time after the date of this prospectus. We will not receive any of the proceeds of the sale of the Shares offered by this prospectus. The aggregate proceeds to the Selling Stockholders from the sale of the Shares will be the purchase price of the Shares less any discounts and commissions. We will not pay any brokers' or underwriters' discounts and commissions in connection with the registration and sale of the Shares covered by this prospectus. The Selling Stockholders reserve the right to accept and, together with their respective agents, to reject, any proposed purchases of Shares to be made directly or through agents.

The Shares offered by this prospectus may be sold from time to time to purchasers:

● directly by the Selling Stockholders, or

● through underwriters, broker-dealers or agents, who may receive compensation in the form of discounts, commissions or agent's commissions from the Selling Stockholders or the purchasers of the Shares.

Any underwriters, broker-dealers or agents who participate in the sale or distribution of the Shares may be deemed to be "underwriters" within the meaning of the Securities Act. As a result, any discounts, commissions or concessions received by any such broker-dealer or agents who are deemed to be underwriters will be deemed to be underwriting discounts and commissions under the Securities Act. Underwriters are subject to the prospectus delivery requirements of the Securities Act and may be subject to certain statutory liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended (the "**Exchange Act**"). We will make copies of this prospectus available to the Selling Stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. To our knowledge, there are currently no plans, arrangements or understandings between the Selling Stockholders and any underwriter, broker-dealer or agent regarding the sale of the Shares by the Selling Stockholders.

The Shares may be sold in one or more transactions at:

● fixed prices;

● prevailing market prices at the time of sale;

● prices related to such prevailing market prices;

● varying prices determined at the time of sale; or

● negotiated prices.

These sales may be effected in one or more transactions:

● on any national securities exchange or quotation service on which the Shares may be listed or quoted at the time of sale, including Nasdaq;

● in the over-the-counter market;

● in transactions otherwise than on such exchanges or services or in the over-the-counter market;

● any other method permitted by applicable law; or

● through any combination of the foregoing.

These transactions may include block transactions or crosses. Crosses are transactions in which the same broker acts as an agent on both sides of the trade.

At the time a particular offering of the Shares is made, a prospectus supplement, if required, will be distributed, which will set forth the name of the Selling Stockholders, the aggregate amount of Shares being offered and the terms of the offering, including, to the extent required, (1) the name or names of any underwriters, broker-dealers or agents, (2) any discounts, commissions and other terms constituting compensation from the Selling Stockholders and (3) any discounts, commissions or concessions allowed or reallowed to be paid to broker-dealers.

The Selling Stockholders will act independently of us in making decisions with respect to the timing, manner, and size of each resale or other transfer. There can be no assurance that the Selling Stockholders will sell any or all of the Shares under this prospectus. Further, we cannot assure you that the Selling Stockholders will not transfer, distribute, devise or gift the Shares by other means not described in this prospectus. In addition, any Shares covered by this prospectus that qualify for sale under Rule 144 of the Securities Act may be sold under Rule 144 rather than under this prospectus. The Shares may be sold in some states only through registered or licensed brokers or dealers. In addition, in some states the Shares may not be sold unless they have been registered or qualified for sale or an exemption from registration or qualification is available and complied with.

The Selling Stockholders and any other person participating in the sale of the Shares will be subject to the Exchange Act. The Exchange Act rules include, without limitation, Regulation M, which may limit the timing of purchases and sales of any of the Shares by the Selling Stockholders and any other person. In addition, Regulation M may restrict the ability of any person engaged in the distribution of the Shares to engage in market-making activities with respect to the particular Shares being distributed. This may affect the marketability of the Shares and the ability of any person or entity to engage in market-making activities with respect to the Shares.

The Selling Stockholders may indemnify any broker or underwriter that participates in transactions involving the sale of the Shares against certain liabilities, including liabilities arising under the Securities Act.

**LEGAL MATTERS**

The validity of the issuance of the securities offered by this prospectus will be passed upon for us by Sichenzia Ross Ference Carmel LLP, New York, New York.

**EXPERTS**

The consolidated balance sheets of the Company as of December 31, 2024 and 2023, the related consolidated statements of operations, stockholders' equity and cash flows for each of the two years in the period ended December 31, 2024 and the related notes, have been audited by Marcum LLP, an independent registered public accounting firm, as stated in their report, which includes an explanatory paragraph as to the Company's ability to continue as a going concern, which is incorporated herein by reference. Such financial statements have been incorporated herein by reference in reliance on the report of such firm given upon their authority as experts in accounting and auditing.

**INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE**

**INFORMATION INCORPORATED BY REFERENCE**

We are incorporating by reference certain information that we have filed with the Commission under the informational requirements of the Exchange Act, which means that we disclose important information to you by referring to another document filed separately with the Company. The information contained in the documents we are incorporating by reference is considered to be a part of this reoffer prospectus, and the information that we later file with the Commission will automatically update and supersede the information contained or incorporated by reference in this reoffer prospectus.

The following documents filed with the Commission are incorporated by reference in this reoffer prospectus:

● Our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on [March 6, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025021260/ea0229992-10k_cyngn.htm) , as amended by Amendment No. 1 on Form 10-K/A, filed with the SEC on [November 14, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025110998/ea0264946-10ka1_cyngn.htm) ;

● Our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, filed on [May 8, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025041094/ea0238882-10q_cyngn.htm) ; our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025, filed on [August 7, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025073134/ea0250100-10q_cyngn.htm) ; and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, filed on [November 19, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025112611/ea0262363-10q_cyngn.htm) .

● Our Current Reports on Form 8-K filed on [January 30, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025008442/ea0229298-8k_cyngn.htm) , [February 6, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025010992/ea0230256-8k_cyngn.htm) , [February 12, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025012916/ea0230778-8k_cyngn.htm) , [February 28, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025018855/ea023250701-8k_cyngn.htm) , [April 25, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025035576/ea0239509-8k_cyngn.htm) , [June 6, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025052228/ea0244984-8k_cyngn.htm) , [June 27, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000117494725000969/ea0247248-8k_cyngn.htm) , [June 30, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025059644/ea0247423-8k_cyngn.htm) , [August 15, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025077501/ea0253465-8k_cyngn.htm) , [September 5, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025085151/ea0256221-8k_cyngn.htm) , [October 6, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025096530/ea026039602-8k_cyngn.htm) , [October 17, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025100008/ea026165301-8k_cyngninc.htm) , [October 24, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025102240/ea0262386-8k_cyngn.htm) , [November 7, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025107677/ea0264618-8k_cyngn.htm) , [December 4, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025118354/ea0268580-8k_cyngn.htm) , and [December 5, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025118839/ea0268738-8k_cyngn.htm) ;

● Our definitive proxy statement on [Schedule 14a](https://www.sec.gov/Archives/edgar/data/1874097/000121390025101251/ea0261865-01.htm) filed on October 22, 2025; and

● The description of our common stock contained in our Registration Statement on [Form 8-A](https://www.sec.gov/Archives/edgar/data/1874097/000121390021053415/ea149008-8a12b_cyngn.htm) , registering our common stock under Section 12(b) under the Exchange Act, filed with the SEC on October 19, 2021.

All documents subsequently filed by us with the Commission under Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (other than current reports on Form 8-K furnished pursuant to Item 2.02 or Item 7.01 of Form 8-K, including any exhibits included with such information, unless otherwise indicated therein) prior to the termination or completion of the offering made pursuant to this prospectus are also incorporated herein by reference and will automatically update and supersede information contained or incorporated by reference in this prospectus.

**WHERE YOU CAN FIND MORE INFORMATION**

We file annual, quarterly and other reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC's website at http://www.sec.gov. Our Annual Report on Form 10-K, as amended by Amendment No. 1 on Form 10-K/A, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including any amendments to those reports, and other information that we file with or furnish to the SEC pursuant to Section 13(a) or 15(d) of the Exchange Act can also be accessed free of charge by linking directly from our website at thecoretecgroup.com. These filings will be available as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Information contained on our website is not part of this prospectus.

The Registrant hereby undertakes to provide without charge to each person, including any beneficial owner, to whom a copy of this prospectus is delivered, upon written or oral request of any such person, a copy of any and all of the information that has been incorporated by reference in this prospectus but not delivered with the prospectus other than the exhibits to those documents, unless the exhibits are specifically incorporated by reference into the information that this prospectus incorporates. Requests for documents should be directed to Cyngn Inc., Attention: Investor Relations, 1344 Terra Bella, Mountain, CA 94043, (650) 924-5905.

**CYNGN INC.**

UP TO 706 SHARES OF COMMON STOCK

REOFFER PROSPECTUS

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT** 

**Item 3. Incorporation of Documents by Reference**

The following documents filed by the Registrant with the Securities and Exchange Commission are incorporated by reference into this Registration Statement (excluding any portions of such documents that have been "furnished" but not "filed" for purposes of the Securities Exchange Act of 1934, as amended (the "Exchange Act")):

● Our Annual Report on [Form 10-K](http://www.sec.gov/Archives/edgar/data/1874097/000121390025021260/ea0229992-10k_cyngn.htm) for the fiscal year ended December 31, 2024, filed with the SEC on March 6, 2025, as amended by Amendment No. 1 on [Form 10-K/A](http://www.sec.gov/Archives/edgar/data/1874097/000121390025110998/ea0264946-10ka1_cyngn.htm) , filed with the SEC on November 14, 2025;

● Our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, filed on [May 8, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025041094/ea0238882-10q_cyngn.htm) ; our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025, filed on [August 7, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025073134/ea0250100-10q_cyngn.htm) ; and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, filed on [November 19, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025112611/ea0262363-10q_cyngn.htm) .

● Our Current Reports on Form 8-K filed on [January 30, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025008442/ea0229298-8k_cyngn.htm) , [February 6, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025010992/ea0230256-8k_cyngn.htm) , [February 12, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025012916/ea0230778-8k_cyngn.htm) , [February 28, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025018855/ea023250701-8k_cyngn.htm) , [April 25, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025035576/ea0239509-8k_cyngn.htm) , [June 6, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025052228/ea0244984-8k_cyngn.htm) , [June 27, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000117494725000969/ea0247248-8k_cyngn.htm) , [June 30, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025059644/ea0247423-8k_cyngn.htm) , [August 15, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025077501/ea0253465-8k_cyngn.htm) , [September 5, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025085151/ea0256221-8k_cyngn.htm) , [October 6, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025096530/ea026039602-8k_cyngn.htm) , [October 17, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025100008/ea026165301-8k_cyngninc.htm) , [October 24, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025102240/ea0262386-8k_cyngn.htm) , [November 7, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025107677/ea0264618-8k_cyngn.htm) , [December 4, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025118354/ea0268580-8k_cyngn.htm) , and [December 5, 2025](https://www.sec.gov/Archives/edgar/data/1874097/000121390025118839/ea0268738-8k_cyngn.htm) ;

● Our definitive proxy statement on [Schedule 14a](https://www.sec.gov/Archives/edgar/data/1874097/000121390025101251/ea0261865-01.htm) filed on October 22, 2025; and

● The description of our common stock contained in our Registration Statement on [Form 8-A](https://www.sec.gov/Archives/edgar/data/1874097/000121390021053415/ea149008-8a12b_cyngn.htm) , registering our common stock under Section 12(b) under the Exchange Act, filed with the SEC on October 19, 2021.

In addition, all documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of the post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of such documents.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein, (or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein), modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

Under no circumstances will any information filed under current items 2.02 or 7.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.

You may request a copy of these filings, at no cost, by writing or telephoning us at the following address: Cyngn Inc., Attention: Corporate Secretary, 1344 Terra Bella, Mountain View, CA 94043, phone number (650) 924-5905.

**ITEM 4. DESCRIPTION OF SECURITIES**

Not applicable.

**ITEM 5. INTERESTS OF NAMES EXPERTS AND COUNSEL**

Not applicable.

**ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS**

As permitted by Delaware law, our certificate of incorporation provides that no director will be liable to us or our stockholders for monetary damages for breach of certain fiduciary duties as a director. The effect of this provision is to restrict our rights and the rights of our stockholders in derivative suits to recover monetary damages against a director for breach of certain fiduciary duties as a director, except that a director will be personally liable for:

● any breach of his or her duty of loyalty to us or our stockholders;

● acts or omissions not in good faith which involve intentional misconduct or a knowing violation of law;

● the payment of dividends or the redemption or purchase of stock in violation of Delaware law; or

● any transaction from which the director derived an improper personal benefit.

This provision does not affect a director's liability under the federal securities laws.

At present, we maintain directors' and officers' liability insurance in order to limit the exposure to liability for indemnification of directors and officers, including liabilities under the Securities Act.

Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

**ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED**

Not applicable.

**ITEM 8. EXHIBITS**

---

| | |
|:---|:---|
| **Exhibit** <br>**Number** | <br>**Description** |
| 4.1 | [2021 Incentive Plan, incorporated by reference to Exhibit 10.5 to the Company's Registration Statement on Form S-1, filed with the SEC on October 15, 2021.](https://www.sec.gov/Archives/edgar/data/1874097/000121390021053094/fs12021a2ex10-5_cyngninc.htm) |
| 4.2 | [Amendment to 2021 Equity Incentive Plan, incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on December 4, 2025.](https://www.sec.gov/Archives/edgar/data/1874097/000121390025118354/ea026858001ex10-1_cyngn.htm) |
| 5.1 | [Opinion of Sichenzia Ross Ference Carmel LLP](ea027394101ex5-1_cyngn.htm) |
| 23.1 | [Consent of Marcum LLP](ea027394101ex23-1_cyngn.htm) |
| 23.2 | [Consent of Sichenzia Ross Ference Carmel LLP (included in the Opinion filed as Exhibit 5.1)](ea027394101ex5-1_cyngn.htm) |
| 24.1 | [Powers of Attorney (included on the signature page to this Registration Statement)](#poa) |
| 107 | [Filing Fee Table](ea027394101ex-fee_cyngn.htm) |

---

**ITEM 9. UNDERTAKINGS**

**1.** The undersigned Registrant
hereby undertakes:

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** To file, during any period
in which offers or sales are being made, a post-effective amendment to this Registration Statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(i)** To include any prospectus required
by Section 10(a)(3) of the Securities Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(ii)** To reflect in the prospectus
any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof)
which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the
form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration
Fee" table in the effective Registration Statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(iii)** To include any material information
with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information
in the Registration Statement;

 

*Provided, however,* that paragraphs (a)(i) and (a)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** That, for the purpose of determining
any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new Registration Statement relating
to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** To remove from registration
by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

**2.** The undersigned Registrant
hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual
report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's
annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be
deemed to be a new Registration Statement relating to the securities offered herein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof.

**3.** Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant
to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that
a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director,
officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Mountain View, CA, on this 28th day of January, 2026.

---

| | |
|:---|:---|
| **CYNGN INC.** | **CYNGN INC.** |
| By: | */s/ Lior Tal* |
|  | *Lior Tal* |
|  | Chief Executive Officer |

---

**POWER OF ATTORNEY** 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Lior Tal, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in their name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Lior Tal | Chief Executive Officer & Chairman of the Board of Directors | January 28, 2026 |
| Lior Tal | and Director (*Principal Executive Officer*) |  |
| /s/ Natalie Russell | Chief Financial Officer | January 28, 2026 |
| Natalie Russell | (*Principal Financial and Accounting Officer*) |  |
| /s/ Karen Macleod | Director | January 28, 2026 |
| Karen Macleod |  |  |
| /s/ James McDonnell | Director | January 28, 2026 |
| James McDonnell |  |  |

---

## Exhibit 5.1

**Exhibit 5.1**

![](ex5-1_001.jpg)

January 28, 2026

***VIA ELECTRONIC TRANSMISSION***

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

**Re: Cyngn Inc. Form S-8 Registration Statement**

Ladies and Gentlemen:

We refer to the above-captioned registration statement on Form S-8 (the "Registration Statement") under the Securities Act of 1933, as amended (the "Act"), filed by Cyngn Inc., a Delaware corporation (the "Company"), with the Securities and Exchange Commission.

We have examined the originals, photocopies, certified copies or other evidence of such records of the Company, certificates of officers of the Company and public officials, and other documents as we have deemed relevant and necessary as a basis for the opinion hereinafter expressed. In such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as certified copies or photocopies and the authenticity of the originals of such latter documents.

Based on our examination mentioned above, we are of the opinion that the securities being issued pursuant to the Registration Statement are duly authorized and will be, when so issued, legally and validly issued, and fully paid and non-assessable.

We hereby consent to the filing of this opinion as Exhibit 5.1 to the Registration Statement. In giving the foregoing consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Act, or the rules and regulations of the Securities and Exchange Commission.

---

| |
|:---|
| Very truly yours, |
| */s/ Sichenzia Ross Ference Carmel LLP* |
| Sichenzia Ross Ference Carmel LLP |

---

1185 AVENUE OF THE AMERICAS \| 31ST FLOOR \| NEW YORK, NY \| 10036

T (212) 930-9700 \| F (212) 930-9725 \| WWW.SRFC.LAW

## Exhibit 23.1

**Exhibit 23.1**

**<u>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</u>**

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 6, 2025 except for the effects of the restatement discussed in Note 15 to the consolidated financial statements, as to which the date is November 14, 2025, which includes an explanatory paragraph as to the Company's ability to continue as a going concern, relating to the consolidated financial statements appearing in the Annual Report on Form 10-K/A (Amendment No. 1) of CYNGN Inc. for the year ended December 31, 2024. We also consent to the reference to us under the heading "Experts" in such Registration Statement.

Marcum LLP

San Francisco, CA

January 28, 2026

## Ex-Filing

?xml version='1.0' encoding='ASCII'? Filing Fee Exhibit

**Ex-Filing Fees**

**CALCULATION OF FILING FEE TABLES**

**S-8**

**Cyngn Inc.**

**Table 1: Newly Registered Securities**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security Type** | **Security Class Title** | **Notes** | **Fee Calculation<br> Rule** | **Amount Registered** | **Proposed Maximum Offering<br> Price Per Unit** | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of Registration Fee** |
| Equity | Common Stock | (1) | Other | 5274003 | $2.35 | $12393907.05 | 0.0001381 | $1711.60 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | $12393907.05 |  | 1711.60 |
| Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: |  |  | 0.00 |
| Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: |  |  | $1711.60 |

---

**__________________________________________ Offering Note(s)**

&nbsp;&nbsp;&nbsp;&nbsp;(1) Pursuant to Rule 416(a) promulgated under the U.S. Securities Act of 1933, as amended, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends, or similar transactions. Represents shares of common stock reserved for future issuance under the Company's Equity Incentive Plan, as amended. Estimated solely for the purpose of calculating the registration fee under Rule 457(c) and (h) of the Securities Act on the basis of the average of the high and low sales price per share of common stock as reported on the Nasdaq Capital Market on January 27, 2026, as reported on the Nasdaq Capital Market